TreeWAS – Variant ID: rs55749608

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability
# Top node	1.000	0.000
Chapter XIII Diseases of the musculoskeletal system and connective tissue	1.000	0.000
Chapter X Diseases of the respiratory system	1.000	0.000
Chapter IV Endocrine, nutritional and metabolic diseases	1.000	0.000
Chapter XIX Injury, poisoning and certain other consequences of external causes	0.999	0.001
E10-E14 Diabetes mellitus	0.999	0.001
Chapter VII Diseases of the eye and adnexa	0.998	0.002
T36-T50 Poisoning by drugs, medicaments and biological substances	0.994	0.006
E10 Insulin-dependent diabetes mellitus	0.990	0.010
J30-J39 Other diseases of upper respiratory tract	0.989	0.011
Chapter IX Diseases of the circulatory system	0.984	0.016
M70-M79 Other soft tissue disorders	0.984	0.016
Chapter XV Pregnancy, childbirth and the puerperium	0.983	0.017
Chapter VI Diseases of the nervous system	0.982	0.018
M45-M49 Spondylopathies	0.979	0.021
M79 Other soft tissue disorders, not elsewhere classified	0.973	0.027
M20-M25 Other joint disorders	0.973	0.027
Chapter XIV Diseases of the genitourinary system	0.972	0.028
Chapter XII Diseases of the skin and subcutaneous tissue	0.971	0.029
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.967	0.033
E11 Non-insulin-dependent diabetes mellitus	0.967	0.033
N17-N19 Renal failure	0.959	0.041
O60-O75 Complications of labour and delivery	0.956	0.044
L00-L08 Infections of the skin and subcutaneous tissue	0.951	0.049
M79.6 Pain in limb	0.944	0.056
M25 Other joint disorders, not elsewhere classified	0.943	0.057
I80-I89 Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified	0.943	0.057
N19 Unspecified renal failure	0.937	0.063
H49-H52 Disorders of ocular muscles, binocular movement, accommodation and refraction	0.937	0.063
I26-I28 Pulmonary heart disease and diseases of pulmonary circulation	0.936	0.064
J90-J94 Other diseases of pleura	0.934	0.066
E10.9 Without complications	0.930	0.070
H53-H54 Visual disturbances and blindness	0.927	0.073
J20-J22 Other acute lower respiratory infections	0.923	0.076
H30-H36 Disorders of choroid and retina	0.923	0.077
N70-N77 Inflammatory diseases of female pelvic organs	0.922	0.078
M79.8 Other specified soft tissue disorders	0.920	0.080
M48 Other spondylopathies	0.918	0.082
N60-N64 Disorders of breast	0.909	0.091
O63 Long labour	0.904	0.096
H36 Retinal disorders in diseases classified elsewhere	0.892	0.108
G90-G99 Other disorders of the nervous system	0.888	0.112
I80 Phlebitis and thrombophlebitis	0.888	0.112
J90 Pleural effusion, not elsewhere classified	0.887	0.113
E11.3 With ophthalmic complications	0.884	0.116
E10.1 With ketoacidosis	0.883	0.117
M50-M54 Other dorsopathies	0.883	0.117
G60-G64 Polyneuropathies and other disorders of the peripheral nervous system	0.882	0.118
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.882	0.118
M79.67 Pain in limb (Ankle and foot)	0.880	0.120
J33 Nasal polyp	0.879	0.121
M79.86 Other specified soft tissue disorders (Lower leg)	0.877	0.123
J34 Other disorders of nose and nasal sinuses	0.875	0.125
T43.2 Other and unspecified antidepressants	0.874	0.126
Chapter XXI Factors influencing health status and contact with health services	0.874	0.126
M48.0 Spinal stenosis	0.873	0.127
J38 Diseases of vocal cords and larynx, not elsewhere classified	0.873	0.127
H36.0 Diabetic retinopathy	0.871	0.129
M25.7 Osteophyte	0.870	0.130
J22 Unspecified acute lower respiratory infection	0.869	0.131
M47 Spondylosis	0.868	0.132
H40-H42 Glaucoma	0.868	0.132
L08 Other local infections of skin and subcutaneous tissue	0.867	0.133
Chapter XX External causes of morbidity and mortality	0.866	0.134
E14 Unspecified diabetes mellitus	0.864	0.136
O63.1 Prolonged second stage (of labour)	0.861	0.139
E10.4 With neurological complications	0.861	0.139
O10-O16 Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium	0.860	0.140
L60-L75 Disorders of skin appendages	0.859	0.141
E11.4 With neurological complications	0.859	0.141
H52 Disorders of refraction and accommodation	0.858	0.142
L03 Cellulitis	0.856	0.144
J80-J84 Other respiratory diseases principally affecting the interstitium	0.854	0.146
S00-S09 Injuries to the head	0.854	0.146
H43-H45 Disorders of vitreous body and globe	0.852	0.148
N73 Other female pelvic inflammatory diseases	0.851	0.149
I27 Other pulmonary heart diseases	0.850	0.150
S30-S39 Injuries to the abdomen, lower back, lumbar spine and pelvis	0.848	0.152
E70-E90 Metabolic disorders	0.845	0.155
J34.8 Other specified disorders of nose and nasal sinuses	0.842	0.158
J09-J18 Influenza and pneumonia	0.839	0.161
H53 Visual disturbances	0.837	0.163
G40-G47 Episodic and paroxysmal disorders	0.832	0.168
I26 Pulmonary embolism	0.831	0.169
I05-I09 Chronic rheumatic heart diseases	0.830	0.170
O80-O84 Delivery	0.830	0.170
J60-J70 Lung diseases due to external agents	0.829	0.171
M23 Internal derangement of knee	0.828	0.172
T43.5 Other and unspecified antipsychotics and neuroleptics	0.828	0.172
M79.65 Pain in limb (Pelvic region and thigh)	0.827	0.173
O68 Labour and delivery complicated by foetal stress [distress]	0.826	0.174
I80.2 Phlebitis and thrombophlebitis of other deep vessels of lower extremities	0.826	0.174
G80-G83 Cerebral palsy and other paralytic syndromes	0.825	0.175
Chapter I Certain infectious and parasitic diseases	0.824	0.176
H55-H59 Other disorders of eye and adnexa	0.823	0.177
Z40-Z54 Persons encountering health services for specific procedures and health care	0.821	0.179
I95-I99 Other and unspecified disorders of the circulatory system	0.818	0.182
M45 Ankylosing spondylitis	0.818	0.182
T43.3 Phenothiazine antipsychotics and neuroleptics	0.818	0.182
E10.3 With ophthalmic complications	0.814	0.186
L02 Cutaneous abscess, furuncle and carbuncle	0.814	0.186
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.814	0.186
J39 Other diseases of upper respiratory tract	0.811	0.189
E50-E64 Other nutritional deficiencies	0.809	0.191
G50-G59 Nerve, nerve root and plexus disorders	0.808	0.192
M40-M43 Deforming dorsopathies	0.808	0.192
L08.9 Local infection of skin and subcutaneous tissue, unspecified	0.807	0.193
J35 Chronic diseases of tonsils and adenoids	0.806	0.194
E87 Other disorders of fluid, electrolyte and acid-base balance	0.803	0.197
M25.4 Effusion of joint	0.802	0.198
E11.5 With peripheral circulatory complications	0.800	0.200
O75 Other complications of labour and delivery, not elsewhere classified	0.799	0.201
M25.5 Pain in joint	0.798	0.202
T90-T98 Sequelae of injuries, of poisoning and of other consequences of external causes	0.795	0.204
N18 Chronic renal failure	0.795	0.205
Z51 Other medical care	0.794	0.206
N73.6 Female pelvic peritoneal adhesions	0.793	0.207
H50 Other strabismus	0.789	0.211
N60 Benign mammary dysplasia	0.788	0.212
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.788	0.212
T80-T88 Complications of surgical and medical care, not elsewhere classified	0.783	0.217
I10-I15 Hypertensive diseases	0.782	0.217
M48.06 Spinal stenosis (Lumbar region)	0.782	0.218
M22 Disorders of patella	0.779	0.221
H54 Blindness and low vision	0.779	0.221
M70 Soft tissue disorders related to use, overuse and pressure	0.779	0.221
J00-J06 Acute upper respiratory infections	0.779	0.221
T51-T65 Toxic effects of substances chiefly nonmedicinal as to source	0.779	0.221
Z51.2 Other chemotherapy	0.775	0.225
H40 Glaucoma	0.774	0.226
N10-N16 Renal tubulo-interstitial diseases	0.774	0.226
N70 Salpingitis and oophoritis	0.774	0.226
G63 Polyneuropathy in diseases classified elsewhere	0.771	0.229
L50-L54 Urticaria and erythema	0.770	0.230
M47.8 Other spondylosis	0.769	0.231
T43.0 Tricyclic and tetracyclic antidepressants	0.769	0.231
I87 Other disorders of veins	0.769	0.231
N17 Acute renal failure	0.768	0.232
M72 Fibroblastic disorders	0.768	0.232
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.767	0.233
Z70-Z76 Persons encountering health services in other circumstances	0.765	0.235
T39.1 4-Aminophenol derivatives	0.765	0.235
J81 Pulmonary oedema	0.764	0.236
S90-S99 Injuries to the ankle and foot	0.764	0.236
J33.9 Nasal polyp, unspecified	0.763	0.237
S60-S69 Injuries to the wrist and hand	0.763	0.237
G93 Other disorders of brain	0.760	0.240
Z51.0 Radiotherapy session	0.760	0.240
J30 Vasomotor and allergic rhinitis	0.759	0.241
M48.02 Spinal stenosis (Cervical region)	0.759	0.241
I26.9 Pulmonary embolism without mention of acute cor pulmonale	0.756	0.244
G99 Other disorders of nervous system in diseases classified elsewhere	0.756	0.244
N61 Inflammatory disorders of breast	0.755	0.245
N00-N08 Glomerular diseases	0.754	0.246
M71 Other bursopathies	0.753	0.247
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion	0.751	0.249
L72 Follicular cysts of skin and subcutaneous tissue	0.748	0.252
H43 Disorders of vitreous body	0.748	0.252
J36 Peritonsillar abscess	0.748	0.252
G45 Transient cerebral ischaemic attacks and related syndromes	0.748	0.252
I27.0 Primary pulmonary hypertension	0.748	0.252
M15-M19 Arthrosis	0.746	0.254
T66-T78 Other and unspecified effects of external causes	0.746	0.254
I89 Other non-infective disorders of lymphatic vessels and lymph nodes	0.746	0.254
H52.0 Hypermetropia	0.746	0.254
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.744	0.256
S20-S29 Injuries to the thorax	0.743	0.257
E00-E07 Disorders of thyroid gland	0.741	0.259
O68.0 Labour and delivery complicated by foetal heart rate anomaly	0.740	0.260
T15-T19 Effects of foreign body entering through natural orifice	0.740	0.260
S80-S89 Injuries to the knee and lower leg	0.739	0.261
M79.63 Pain in limb (Forearm)	0.738	0.262
Chapter XXII Codes for special purposes	0.735	0.265
H53.0 Amblyopia ex anopsia	0.735	0.265
T79-T79 Certain early complications of trauma	0.732	0.268
E14.9 Without complications	0.732	0.268
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.732	0.268
O13 Gestational [pregnancy-induced] hypertension without significant proteinuria	0.727	0.273
O80 Single spontaneous delivery	0.727	0.273
Chapter XVII Congenital malformations, deformations and chromosomal abnormalities	0.725	0.275
M25.77 Osteophyte (Ankle and foot)	0.723	0.277
E20-E35 Disorders of other endocrine glands	0.723	0.277
J38.3 Other diseases of vocal cords	0.720	0.280
M79.62 Pain in limb (Upper arm)	0.720	0.280
I86 Varicose veins of other sites	0.719	0.280
N64 Other disorders of breast	0.719	0.281
M50 Cervical disk disorders	0.718	0.282
Z71 Persons encountering health services for other counselling and medical advice, not elsewhere classified	0.717	0.283
Chapter XVI Certain conditions originating in the perinatal period	0.717	0.283
M95-M99 Other disorders of the musculoskeletal system and connective tissue	0.717	0.283
M91-M94 Chondropathies	0.717	0.283
M86-M90 Other osteopathies	0.717	0.283
M60-M63 Disorders of muscles	0.717	0.283
M00-M03 Infectious arthropathies	0.717	0.283
E40-E46 Malnutrition	0.717	0.283
T33-T35 Frostbite	0.716	0.283
T29-T32 Burns and corrosions of multiple and unspecified body regions	0.716	0.283
T26-T28 Burns and corrosions confined to eye and internal organs	0.716	0.283
T20-T25 Burns and corrosions of external body surface, specified by site	0.716	0.283
T08-T14 Injuries to unspecified part of trunk, limb or body region	0.716	0.283
T00-T07 Injuries involving multiple body regions	0.716	0.283
S10-S19 Injuries to the neck	0.716	0.283
E13 Other specified diabetes mellitus	0.716	0.284
E12 Malnutrition-related diabetes mellitus	0.716	0.284
H46-H48 Disorders of optic nerve and visual pathways	0.715	0.285
H15-H22 Disorders of sclera, cornea, iris and ciliary body	0.715	0.285
H10-H13 Disorders of conjunctiva	0.715	0.285
I08 Multiple valve diseases	0.715	0.285
I85 Oesophageal varices	0.714	0.286
M21 Other acquired deformities of limbs	0.713	0.286
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.712	0.288
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.712	0.288
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.712	0.288
T46 Poisoning by agents primarily affecting the cardiovascular system	0.712	0.288
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.712	0.288
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.712	0.288
T41 Poisoning by anaesthetics and therapeutic gases	0.712	0.288
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.712	0.288
T36 Poisoning by systemic antibiotics	0.712	0.288
S70-S79 Injuries to the hip and thigh	0.712	0.288
H52.1 Myopia	0.712	0.288
J85-J86 Suppurative and necrotic conditions of lower respiratory tract	0.710	0.290
E10.8 With unspecified complications	0.710	0.290
E10.7 With multiple complications	0.710	0.290
E10.6 With other specified complications	0.710	0.290
E10.5 With peripheral circulatory complications	0.710	0.290
E10.2 With renal complications	0.710	0.290
E10.0 With coma	0.710	0.290
L03.9 Cellulitis, unspecified	0.710	0.290
M51 Other intervertebral disk disorders	0.709	0.291
J37 Chronic laryngitis and laryngotracheitis	0.709	0.291
T82 Complications of cardiac and vascular prosthetic devices, implants and grafts	0.708	0.292
L03.8 Cellulitis of other sites	0.707	0.293
I30-I52 Other forms of heart disease	0.707	0.293
J38.0 Paralysis of vocal cords and larynx	0.706	0.294
G62 Other polyneuropathies	0.706	0.294
I00-I02 Acute rheumatic fever	0.705	0.294
M77 Other enthesopathies	0.705	0.295
M76 Enthesopathies of lower limb, excluding foot	0.705	0.295
M73 Soft tissue disorders in diseases classified elsewhere	0.705	0.295
O85-O92 Complications predominantly related to the puerperium	0.704	0.295
G70-G73 Diseases of myoneural junction and muscle	0.704	0.296
G10-G14 Systemic atrophies primarily affecting the central nervous system	0.704	0.296
G00-G09 Inflammatory diseases of the central nervous system	0.704	0.296
N99-N99 Other disorders of the genitourinary system	0.703	0.297
I27.2 Other secondary pulmonary hypertension	0.703	0.297
O14 Gestational [pregnancy-induced] hypertension with significant proteinuria	0.703	0.297
M45.X9 Ankylosing spondylitis (Site unspecified)	0.703	0.297
M25.71 Osteophyte (Shoulder region)	0.702	0.298
M49 Spondylopathies in diseases classified elsewhere	0.702	0.298
N63 Unspecified lump in breast	0.701	0.298
M25.46 Effusion of joint (Lower leg)	0.701	0.299
M54 Dorsalgia	0.701	0.299
M25.50 Pain in joint (Multiple sites)	0.701	0.299
W00-W19 Falls	0.700	0.300
I95 Hypotension	0.700	0.300
M25.76 Osteophyte (Lower leg)	0.699	0.300
M46 Other inflammatory spondylopathies	0.698	0.301
M79.9 Soft tissue disorder, unspecified	0.698	0.302
M79.7 Fibromyalgia	0.698	0.302
M79.5 Residual foreign body in soft tissue	0.698	0.302
M79.4 Hypertrophy of (infrapatellar) fat pad	0.698	0.302
M79.3 Panniculitis, unspecified	0.698	0.302
M79.2 Neuralgia and neuritis, unspecified	0.698	0.302
M79.1 Myalgia	0.698	0.302
H59 Postprocedural disorders of eye and adnexa, not elsewhere classified	0.698	0.302
M36 Systemic disorders of connective tissue in diseases classified elsewhere	0.697	0.302
M34 Systemic sclerosis	0.697	0.302
M33 Dermatopolymyositis	0.697	0.302
M32 Systemic lupus erythematosus	0.697	0.302
M30 Polyarteritis nodosa and related conditions	0.697	0.302
L10-L14 Bullous disorders	0.696	0.304
T39.0 Salicylates	0.696	0.304
S39 Other and unspecified injuries of abdomen, lower back and pelvis	0.695	0.305
A50-A64 Infections with a predominantly sexual mode of transmission	0.695	0.305
O20-O29 Other maternal disorders predominantly related to pregnancy	0.694	0.305
M80-M85 Disorders of bone density and structure	0.694	0.306
T43.9 Psychotropic drug, unspecified	0.693	0.306
T43.8 Other psychotropic drugs, not elsewhere classified	0.693	0.306
T43.6 Psychostimulants with abuse potential	0.693	0.306
T43.4 Butyrophenone and thioxanthene neuroleptics	0.693	0.306
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.693	0.306
E11.8 With unspecified complications	0.693	0.307
E11.7 With multiple complications	0.693	0.307
E11.6 With other specified complications	0.693	0.307
E11.2 With renal complications	0.693	0.307
E11.1 With ketoacidosis	0.693	0.307
E11.0 With coma	0.693	0.307
O72 Postpartum haemorrhage	0.692	0.308
J13 Pneumonia due to Streptococcus pneumoniae	0.692	0.308
G63.2 Diabetic polyneuropathy	0.692	0.308
G81 Hemiplegia	0.692	0.308
L03.0 Cellulitis of finger and toe	0.692	0.308
G59 Mononeuropathy in diseases classified elsewhere	0.691	0.309
J33.0 Polyp of nasal cavity	0.689	0.311
I80.1 Phlebitis and thrombophlebitis of femoral vein	0.688	0.312
H40.1 Primary open-angle glaucoma	0.688	0.312
E87.5 Hyperkalaemia	0.688	0.312
M48.07 Spinal stenosis (Lumbosacral region)	0.687	0.313
O00-O08 Pregnancy with abortive outcome	0.687	0.313
E14.3 With ophthalmic complications	0.686	0.314
O63.0 Prolonged first stage (of labour)	0.686	0.314
I80.3 Phlebitis and thrombophlebitis of lower extremities, unspecified	0.686	0.314
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.686	0.314
L03.3 Cellulitis of trunk	0.686	0.314
O74 Complications of anaesthesia during labour and delivery	0.685	0.314
O73 Retained placenta and membranes, without haemorrhage	0.685	0.314
O71 Other obstetric trauma	0.685	0.314
O69 Labour and delivery complicated by umbilical cord complications	0.685	0.314
O67 Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified	0.685	0.314
O66 Other obstructed labour	0.685	0.314
O65 Obstructed labour due to maternal pelvic abnormality	0.685	0.314
O64 Obstructed labour due to malposition and malpresentation of foetus	0.685	0.314
O62 Abnormalities of forces of labour	0.685	0.314
O61 Failed induction of labour	0.685	0.314
O60 Preterm delivery	0.685	0.314
J39.2 Other diseases of pharynx	0.684	0.316
L20-L30 Dermatitis and eczema	0.684	0.316
L73 Other follicular disorders	0.684	0.316
L02.4 Cutaneous abscess, furuncle and carbuncle of limb	0.683	0.317
M79.87 Other specified soft tissue disorders (Ankle and foot)	0.683	0.317
L05 Pilonidal cyst	0.681	0.318
L04 Acute lymphadenitis	0.681	0.318
L01 Impetigo	0.681	0.318
L00 Staphylococcal scalded skin syndrome	0.681	0.318
M47.82 Other spondylosis (Cervical region)	0.681	0.319
Z42 Follow-up care involving plastic surgery	0.680	0.320
J92 Pleural plaque	0.679	0.321
L55-L59 Radiation-related disorders of the skin and subcutaneous tissue	0.678	0.322
H43.1 Vitreous haemorrhage	0.678	0.322
S32 Fracture of lumbar spine and pelvis	0.677	0.323
N72 Inflammatory disease of cervix uteri	0.677	0.323
J61 Pneumoconiosis due to asbestos and other mineral fibres	0.677	0.323
M79.68 Pain in limb (Other)	0.677	0.323
M79.64 Pain in limb (Hand)	0.677	0.323
M79.61 Pain in limb (Shoulder region)	0.677	0.323
J32 Chronic sinusitis	0.677	0.323
M25.9 Joint disorder, unspecified	0.676	0.324
M25.8 Other specified joint disorders	0.676	0.324
M25.6 Stiffness of joint, not elsewhere classified	0.676	0.324
M25.3 Other instability of joint	0.676	0.324
M25.2 Flail joint	0.676	0.324
M25.1 Fistula of joint	0.676	0.324
M25.0 Haemarthrosis	0.676	0.324
I88 Nonspecific lymphadenitis	0.676	0.324
I82 Other venous embolism and thrombosis	0.676	0.324
I81 Portal vein thrombosis	0.676	0.324
M65-M68 Disorders of synovium and tendon	0.676	0.324
J35.0 Chronic tonsillitis	0.675	0.325
M31 Other necrotising vasculopathies	0.675	0.325
J38.1 Polyp of vocal cord and larynx	0.675	0.325
E87.7 Fluid overload	0.673	0.327
G58 Other mononeuropathies	0.672	0.328
H51 Other disorders of binocular movement	0.671	0.328
H49 Paralytic strabismus	0.671	0.328
I28 Other diseases of pulmonary vessels	0.671	0.329
N75 Diseases of Bartholin's gland	0.670	0.330
W20-W49 Exposure to inanimate mechanical forces	0.670	0.330
J94 Other pleural conditions	0.669	0.330
J91 Pleural effusion in conditions classified elsewhere	0.669	0.330
M47.9 Spondylosis, unspecified	0.669	0.331
E87.3 Alkalosis	0.668	0.332
Z46 Fitting and adjustment of other devices	0.667	0.333
I51 Complications and ill-defined descriptions of heart disease	0.666	0.334
E07 Other disorders of thyroid	0.666	0.334
M79.69 Pain in limb (Site unspecified)	0.665	0.335
H53.8 Other visual disturbances	0.664	0.336
M79.60 Pain in limb (Multiple sites)	0.663	0.337
J21 Acute bronchiolitis	0.662	0.338
J20 Acute bronchitis	0.662	0.338
O80.0 Spontaneous vertex delivery	0.662	0.338
O94-O99 Other obstetric conditions, not elsewhere classified	0.662	0.338
H32 Chorioretinal disorders in diseases classified elsewhere	0.662	0.338
H31 Other disorders of choroid	0.662	0.338
H30 Chorioretinal inflammation	0.662	0.338
G41 Status epilepticus	0.662	0.338
S09 Other and unspecified injuries of head	0.661	0.339
G99.2 Myelopathy in diseases classified elsewhere	0.661	0.339
M25.56 Pain in joint (Lower leg)	0.661	0.339
N77 Vulvovaginal ulceration and inflammation in diseases classified elsewhere	0.661	0.339
N76 Other inflammation of vagina and vulva	0.661	0.339
N74 Female pelvic inflammatory disorders in diseases classified elsewhere	0.661	0.339
N71 Inflammatory disease of uterus, except cervix	0.661	0.339
M23.2 Derangement of meniscus due to old tear or injury	0.660	0.340
H54.0 Blindness, both eyes	0.659	0.341
M79.89 Other specified soft tissue disorders (Site unspecified)	0.659	0.341
M79.88 Other specified soft tissue disorders (Other)	0.659	0.341
M79.85 Other specified soft tissue disorders (Pelvic region and thigh)	0.659	0.341
M79.84 Other specified soft tissue disorders (Hand)	0.659	0.341
M79.83 Other specified soft tissue disorders (Forearm)	0.659	0.341
M79.82 Other specified soft tissue disorders (Upper arm)	0.659	0.341
M79.81 Other specified soft tissue disorders (Shoulder region)	0.659	0.341
M79.80 Other specified soft tissue disorders (Multiple sites)	0.659	0.341
X40-X49 Accidental poisoning by and exposure to noxious substances	0.658	0.341
J95-J99 Other diseases of the respiratory system	0.658	0.341
M48.9 Spondylopathy, unspecified	0.658	0.342
M48.8 Other specified spondylopathies	0.658	0.342
M48.5 Collapsed vertebra, not elsewhere classified	0.658	0.342
M48.4 Fatigue fracture of vertebra	0.658	0.342
M48.3 Traumatic spondylopathy	0.658	0.342
M48.2 Kissing spine	0.658	0.342
M48.1 Ankylosing hyperostosis [Forestier]	0.658	0.342
H53.4 Visual field defects	0.657	0.343
M79.66 Pain in limb (Lower leg)	0.656	0.343
J33.8 Other polyp of sinus	0.656	0.344
H52.2 Astigmatism	0.656	0.344
G61 Inflammatory polyneuropathy	0.655	0.345
J93 Pneumothorax	0.655	0.345
E61 Deficiency of other nutrient elements	0.654	0.346
M35 Other systemic involvement of connective tissue	0.654	0.346
H40.2 Primary angle-closure glaucoma	0.654	0.346
G20-G26 Extrapyramidal and movement disorders	0.653	0.347
J18 Pneumonia, organism unspecified	0.653	0.347
S00 Superficial injury of head	0.653	0.347
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.652	0.348
M25.78 Osteophyte (Other)	0.652	0.348
S06 Intracranial injury	0.651	0.349
E87.6 Hypokalaemia	0.650	0.350
G45.9 Transient cerebral ischaemic attack, unspecified	0.649	0.351
Y45 Analgesics, antipyretics and anti-inflammatory drugs	0.649	0.351
O63.9 Long labour, unspecified	0.648	0.351
O63.2 Delayed delivery of second twin, triplet, etc.	0.648	0.351
E86 Volume depletion	0.648	0.352
M25.74 Osteophyte (Hand)	0.648	0.352
H34 Retinal vascular occlusions	0.647	0.353
M43 Other deforming dorsopathies	0.647	0.353
M22.2 Patellofemoral disorders	0.646	0.354
V20-V29 Motorcycle rider injured in transport accident	0.645	0.354
O75.2 Pyrexia during labour, not elsewhere classified	0.645	0.355
E11.9 Without complications	0.645	0.355
X60-X84 Intentional self-harm	0.645	0.355
S02 Fracture of skull and facial bones	0.645	0.355
I51.7 Cardiomegaly	0.645	0.355
I87.2 Venous insufficiency (chronic) (peripheral)	0.644	0.356
L02.2 Cutaneous abscess, furuncle and carbuncle of trunk	0.643	0.357
G30-G32 Other degenerative diseases of the nervous system	0.642	0.357
I84 Haemorrhoids	0.642	0.358
M20 Acquired deformities of fingers and toes	0.642	0.358
G43 Migraine	0.642	0.358
J69 Pneumonitis due to solids and liquids	0.641	0.358
H50.0 Convergent concomitant strabismus	0.641	0.359
J31 Chronic rhinitis, nasopharyngitis and pharyngitis	0.640	0.359
H36.8 Other retinal disorders in diseases classified elsewhere	0.640	0.360
N73.9 Female pelvic inflammatory disease, unspecified	0.640	0.360
N62 Hypertrophy of breast	0.639	0.361
N60.8 Other benign mammary dysplasias	0.637	0.363
S01 Open wound of head	0.637	0.363
S50-S59 Injuries to the elbow and forearm	0.637	0.363
G97 Postprocedural disorders of nervous system, not elsewhere classified	0.637	0.363
G96 Other disorders of central nervous system	0.637	0.363
G95 Other diseases of spinal cord	0.637	0.363
G94 Other disorders of brain in diseases classified elsewhere	0.637	0.363
G91 Hydrocephalus	0.637	0.363
G90 Disorders of autonomic nervous system	0.637	0.363
G98 Other disorders of nervous system, not elsewhere classified	0.637	0.363
G92 Toxic encephalopathy	0.637	0.363
I80.9 Phlebitis and thrombophlebitis of unspecified site	0.637	0.363
I80.8 Phlebitis and thrombophlebitis of other sites	0.637	0.363
I80.0 Phlebitis and thrombophlebitis of superficial vessels of lower extremities	0.637	0.363
M23.3 Other meniscus derangements	0.636	0.364
M23.8 Other internal derangements of knee	0.635	0.365
N18.3 Chronic kidney disease, stage 3	0.635	0.365
O75.6 Delayed delivery after spontaneous or unspecified rupture of membranes	0.634	0.366
M53 Other dorsopathies, not elsewhere classified	0.633	0.367
T42.4 Benzodiazepines	0.633	0.367
G60 Hereditary and idiopathic neuropathy	0.633	0.367
G64 Other disorders of peripheral nervous system	0.633	0.367
M70.4 Prepatellar bursitis	0.632	0.367
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.632	0.368
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.632	0.368
T39.4 Antirheumatics, not elsewhere classified	0.632	0.368
T39.2 Pyrazolone derivatives	0.632	0.368
M25.75 Osteophyte (Pelvic region and thigh)	0.632	0.368
T90 Sequelae of injuries of head	0.631	0.369
N17.9 Acute renal failure, unspecified	0.631	0.369
T83 Complications of genito-urinary prosthetic devices, implants and grafts	0.631	0.369
J33.1 Polypoid sinus degeneration	0.630	0.370
N60.2 Fibroadenosis of breast	0.630	0.370
B35-B49 Mycoses	0.629	0.371
G82 Paraplegia and tetraplegia	0.628	0.372
M24 Other specific joint derangements	0.628	0.372
J34.1 Cyst and mucocele of nose and nasal sinus	0.627	0.373
J34.0 Abscess, furuncle and carbuncle of nose	0.627	0.373
N60.4 Mammary duct ectasia	0.627	0.373
Z49 Care involving dialysis	0.627	0.373
N70.1 Chronic salpingitis and oophoritis	0.626	0.373
M48.09 Spinal stenosis (Site unspecified)	0.626	0.374
M48.08 Spinal stenosis (Sacral and sacrococcygeal region)	0.626	0.374
M48.05 Spinal stenosis (Thoracolumbar region)	0.626	0.374
M48.04 Spinal stenosis (Thoracic region)	0.626	0.374
M48.03 Spinal stenosis (Cervicothoracic region)	0.626	0.374
M48.01 Spinal stenosis (Occipito-atlanto-axial region)	0.626	0.374
M48.00 Spinal stenosis (Multiple sites in spine)	0.626	0.374
J38.7 Other diseases of larynx	0.626	0.374
Z71.1 Person with feared complaint in whom no diagnosis is made	0.626	0.374
Z48 Other surgical follow-up care	0.626	0.374
J38.6 Stenosis of larynx	0.626	0.374
J38.5 Laryngeal spasm	0.626	0.374
J38.4 Oedema of larynx	0.626	0.374
J38.2 Nodules of vocal cords	0.626	0.374

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations